What is Profound Medical's SG&A?

Profound Medical (PROF) reported SG&A of $6.59M in Q1 2026.

How has Profound Medical's SG&A changed year-over-year?

Profound Medical's SG&A decreased by 19.7% year-over-year, from $8.21M to $6.59M.

What is the long-term trend for Profound Medical's SG&A?

Over 2 years (2023 to 2025), Profound Medical's SG&A has grown at a 31.5% compound annual growth rate (CAGR), from $18.54M to $32.05M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Profound Medical PROF SG&A

SG&A at other companies

Intuitive SurgicalISRG

$613.3M+8.9%

BioventusBVS

$78.33M+6.6%

Other financials

Income statement

See full

Revenue$5.3M+104%

Gross profit$3.8M+107%

Operating income-$8.0M+28.2%

Net income-$7.1M+34.2%

EPS (diluted)$0.19-47.2%

Balance sheet

See full

Cash & equivalents$50.3M+8.3%

Total debt$7.5M+52.8%

Total equity$59.4M+17.0%

Total assets$73.5M+20.7%

Cash flow

See full

Operating cash flow-$8.6M-3.6%

CapEx$44.0K—

Free cash flow-$9.6M—

Valuation

See full

Market cap$241.65M+30.7%

Enterprise value$198.81M+28.7%

P/S12.8×-2.8×

Profitability

See full

Gross margin71.1%+3.4pp

Operating margin-202.6%-51.3pp

Net margin-206.8%-39.0pp

FCF margin-238.4%—

Returns & leverage

See full

Return on equity-70.6%+4.8pp

Debt / equity0.1×0.0×

Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Profound Medical's SG&A?: Profound Medical (PROF) reported SG&A of $6.59M in Q1 2026.
How has Profound Medical's SG&A changed year-over-year?: Profound Medical's SG&A decreased by 19.7% year-over-year, from $8.21M to $6.59M.
What is the long-term trend for Profound Medical's SG&A?: Over 2 years (2023 to 2025), Profound Medical's SG&A has grown at a 31.5% compound annual growth rate (CAGR), from $18.54M to $32.05M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.